National Institute On Aging (nia)
Clinical trials sponsored by National Institute On Aging (nia), explained in plain language.
-
ER pharmacists tackle dementia medication risks
Knowledge-focused CompletedThis study looked at whether emergency department pharmacists can safely reduce the use of certain brain-active medications in people with dementia or mild cognitive impairment. Researchers worked with 300 participants to see if pharmacists could communicate medication changes to…
Phase: NA • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jul 02, 2026 01:00 UTC
-
Growth hormone infusions tested for immune boost in healthy men
Knowledge-focused CompletedThis completed Phase 1 study tested whether giving growth hormone (Norditropin) through a small pump under the skin could improve immune function in healthy men aged 25 to 50. Participants received either growth hormone or a placebo for up to 4 weeks, with frequent blood and urin…
Phase: PHASE1 • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists probe how aging skin cells respond to wounds
Knowledge-focused CompletedThis study looks at how aging cells in the skin respond to small injuries. Researchers will take small skin samples from healthy adults aged 20-39 or 70+ to see if older people have more senescent (non-replicating) cells around wounds. The goal is to better understand aging and a…
Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Cannabis-Like drugs may unlock diabetes secrets
Knowledge-focused CompletedThis study tested two drugs that act on the body's endocannabinoid system—nabilone and CP-945,598—to see how they affect insulin production and sensitivity. Forty-five healthy men aged 21 to 55 took part in four visits, each receiving a different drug combination. The goal was to…
Phase: PHASE1 • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Alzheimer's drug candidate BNC passes first safety check in healthy seniors
Knowledge-focused CompletedThis early-phase study tested a single dose of bisnorcymserine (BNC) in 75 healthy volunteers aged 55 and older to see how safe it is and how the body processes it. BNC is designed to block a brain chemical that may affect communication between nerve cells, potentially helping wi…
Phase: PHASE1 • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could COPD drug help control blood sugar? new study explores
Knowledge-focused CompletedThis completed Phase 1 trial studied how two drugs, roflumilast (used for COPD) and sitagliptin (used for diabetes), affect blood sugar and gut hormones in 29 healthy volunteers aged 21-55. Participants received each drug alone, together, or a placebo, then drank a nutritional sh…
Phase: PHASE1 • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists track red blood cell lifespan to solve anemia mystery in seniors
Knowledge-focused CompletedThis study looked at why many older adults (over 70) have anemia even when doctors can't find a reason. Researchers measured how long red blood cells live in younger and older adults by marking them with a vitamin called Biotin. The goal was to understand if faster red blood cell…
Phase: PHASE1 • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Brain fuel drink tested in healthy seniors – no cure, just science
Knowledge-focused CompletedThis study looked at whether a special drink called ketone ester can improve brain energy use and thinking skills in healthy adults aged 55 and older who have metabolic syndrome. Participants took the drink or a placebo for 28 days and had brain scans and memory tests. The goal w…
Phase: NA • Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC